Claims
- 1. A nitrogen-containing heterocyclic compound represented by the formula ##STR158## wherein one of R.sub.1 and R.sub.2 represents a loweralkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom, a lower alkyl group or a phenyl lower alkyl group; R.sub.3 represents a hydrogen atom, a lower alkyl group, a phenyl group, or a phenyl lower alkyl group; X represents a sulfur atom, or the group shown by ##STR159## wherein m represents 1 or 2; and Y represents an ethylene group which may be substituted by a lower alkyl group, a trimethylene group, a tetramethylene group, a vinylene group which may be substituted by lower alkyl group, or the group shown by ##STR160## wherein R.sub.5 represents a hydrogen atom, a lower alkyl group, a trifluoromethyl group, or a phenyl group; said Y represents the aforesaid group other than an ethylene group, when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other of them is a hydrogen atom, and the pharmaceutically acceptable non-toxic salts thereof.
- 2. A nitrogen-containing heterocyclic compound as claimed in claim 1 wherein one of R.sub.1 and R.sub.2 represents a lower alkyl group, a phenyl group, a halophenyl group, or a lower alkoxyphenyl group and the other of them represents a hydrogen atom or a lower alkyl group; R.sub.3 represents a hydrogen atom; X represents a sulfur atom, or the group shown by ##STR161## wherein m represents 1 or 2; Y represents an ethylene group which may be substituted by a lower alkyl group, a trimethylene group, a tetramethylene group, or a vinylene group which may be substituted by a lower alkyl group; said Y represents the aforesaid group other than an ethylene group when one of said R.sub.1 and R.sub.2 is a lower alkyl group and the other of them is a hydrogen atom, and the pharmaceutically acceptable non-toxic salts thereof.
- 3. The nitrogen containing heterocyclic compounds as claimed in claim 2 wherein R.sub.1 is a hydrogen atom;
- R.sub.2 is a phenyl group;
- R.sub.3 is a hydrogen atom;
- X is a sulfur atom or the group shown by ##STR162## wherein m is 1 or 2; and Y is an ethylene group.
- 4. 5-oxo-7-phenyl-2,3,5-trihydrothiazolo[3,2-a]pyridine as claimed in claim 3.
- 5. 5-oxo-7-phenyl-2,3,5-trihydrothiazolo[3,2-a]pyridine-1-oxide as claimed in claim 3.
- 6. A nitrogen containing heterocyclic compound as claimed in claim 2 wherein one of R.sub.1 and R.sub.2 is a lower alkyl group, a phenyl group, a halophenyl group or a lower alkoxyphenyl group and the other of them is a hydrogen atom or a lower alkyl group, R.sub.3 is a hydrogen atom, X is a sulfur atom, or the group shown by ##STR163## wherein m is 1 or 2, Y is an ethylene group substituted by lower alkyl group or a vinylene group which may be substituted by lower alkyl group.
- 7. 5-oxo-7-phenyl-5-hydrothiazolo[3,2-a]pyridine as claimed in claim 6.
- 8. 3-methyl-5-oxo-7-phenyl-5-hydrothiazolo[3,2-a]pyridine as claimed in claim 6.
- 9. An analgesic anti-inflammatory composition comprising an analgesic or an anti-inflammatory effective amount of the compound of claim 1 and a pharmaceutically analgesic or an anti-inflammatory acceptable carrier or excipient.
- 10. A composition as claimed in claim 9 wherein said excipient is selected from the group consisting of calcium carbonate, calcium phosphate, starch, sucrose, lactose, talc, magnesium stearate, gelatin, polyvinyl pyrrolidone, gum arabic, sorbitol, microcrystalline cellulose, polyethylene glycol, silica, and sodium lauryl sulfate.
- 11. A composition as claimed in claim 9, in the form of an aqueous or oily suspension, a syrup, or an elixir.
- 12. A composition as claimed in claim 9, in the form of a suppository.
- 13. A method of inducing an analgesic or anti-inflammatory effect comprising administering an analgesic or an anti-inflammatory effective amount of the composition of claim 9.
Priority Claims (5)
Number |
Date |
Country |
Kind |
51-87486 |
Jul 1976 |
JPX |
|
51-158228 |
Dec 1976 |
JPX |
|
52-36384 |
Mar 1977 |
JPX |
|
52-42423 |
Apr 1977 |
JPX |
|
52-464 |
May 1977 |
JPX |
|
Parent Case Info
This application is a divisional application of U.S. Pat. Application Ser. No. 876,517, filed Feb. 9, 1978, now U.S. Pat. No. 4,186,200 issued Jan. 29, 1980, which is a continuation-in-part application of U.S. Ser. No. 814,325, filed July 11, 1977, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3334091 |
Houlihan |
Aug 1967 |
|
3646022 |
Graf et al. |
Feb 1972 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
45-11505 |
Apr 1970 |
JPX |
562978 |
Jul 1978 |
SUX |
Non-Patent Literature Citations (1)
Entry |
Chem. Abstracts 1947-1956, Collective Index, p. 12588s, Chem. Ber. 86 (1953), pp. 468-472. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
876517 |
Feb 1978 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
814325 |
Jul 1977 |
|